NIH ethics concerns: consulting arrangements and outside awards : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Eighth Congress, second session, May 12, May 18, and June 22, 2004, Volumes 73-78
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations
U.S. G.P.O., 2004 - Medical - 819 pages
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
accept activities Advisory agreement approval authority Biospect biotechnology Blue Ribbon Panel bona fide awards cash awards Center Chairman Barton clinical committee compensation concerns conduct conflict of interest consulting arrangements Correlogic Counsel CRADA CRDA DeGette deputy ethics counselor Director drug Elias Zerhouni employee's official entity ethics officials ethics program extramural federal financial disclosure reports financial interests gifts Government Ethics grants Greenwood Harold Varmus intramural involved issues jnoX Kington Klausner Liotta matter National Cancer Institute National Institutes NEAC NIH employees NIH Ethics NIH scientists NIH's Office of Government official duties Okay ovarian cancer Petricoin prohibited source proteomics question received recommendations recusal regulations request responsibilities rules scientific senior specific staff statute Stearns stock options subcommittee substantially affected Swindell tion Title 42 University of Pittsburgh Varmus Walden Zerhouni